Cargando…

Patient-derived organoids as a predictive biomarker for treatment response in cancer patients

Effective predictive biomarkers are needed to enable personalized medicine and increase treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and treatment costs. Patient-derived organoids (PDOs) enable individualized tumour response testing. Since 2018, 17 publica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wensink, G. Emerens, Elias, Sjoerd G., Mullenders, Jasper, Koopman, Miriam, Boj, Sylvia F., Kranenburg, Onno W., Roodhart, Jeanine M. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042051/ https://www.ncbi.nlm.nih.gov/pubmed/33846504 http://dx.doi.org/10.1038/s41698-021-00168-1

Ejemplares similares

Mismatch Repair Status in Patient-Derived Colorectal Cancer Organoids Does Not Affect Intrinsic Tumor Cell Sensitivity to Systemic Therapy
por: Küçükköse, Emre, et al.
Publicado: (2021)

External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide Cohort
por: Bolhuis, Karen, et al.
Publicado: (2022)

Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases
por: Wensink, G E, et al.
Publicado: (2023)

External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily Practice
por: Hamers, Patricia A. H., et al.
Publicado: (2022)

Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort
por: Zwart, Koen, et al.
Publicado: (2023)

Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer
por: Strating, Esther, et al.
Publicado: (2023)

Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice
por: Küçükköse, Emre, et al.
Publicado: (2022)

Prognostic value of Lynch syndrome, BRAF(V600E) , and RAS mutational status in dMMR/MSI‐H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts
por: Zwart, Koen, et al.
Publicado: (2023)

Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses
por: Raimondi, Giulia, et al.
Publicado: (2020)

Mode of progression after radioembolization in patients with colorectal cancer liver metastases
por: van Roekel, Caren, et al.
Publicado: (2020)

ASO Author Reflections: Clinical Outcome After Upfront Curative-Intent Local Treatment of Metastases in Patient with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer
por: Zwart, Koen, et al.
Publicado: (2023)

Albuminuria Is Associated with Traditional Cardiovascular Risk Factors and Viral Load in HIV-Infected Patients in Rural South Africa
por: Wensink, G. Emerens, et al.
Publicado: (2015)

Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids
por: Vonk, Annelotte M., et al.
Publicado: (2020)

Establishment of Pancreatic Organoids from Normal Tissue and Tumors
por: Driehuis, Else, et al.
Publicado: (2020)

Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study
por: Peters, Niek A., et al.
Publicado: (2022)

Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients
por: Chen, Lifeng, et al.
Publicado: (2022)

Patient-Derived Organoids of Cholangiocarcinoma
por: Maier, Christopher Fabian, et al.
Publicado: (2021)

Loss of Neuropilin-2 in Murine Mesenchymal-like Colon Cancer Organoids Causes Mesenchymal-to-Epithelial Transition and an Acquired Dependency on Insulin-Receptor Signaling and Autophagy
por: Poghosyan, Susanna, et al.
Publicado: (2022)

Patients' perspectives on the derivation and use of organoids
por: Bollinger, Juli, et al.
Publicado: (2021)

Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
por: Zhou, Zilong, et al.
Publicado: (2021)

Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma
por: De Crignis, Elisa, et al.
Publicado: (2021)

Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma
por: Dijkstra, Krijn K., et al.
Publicado: (2021)

Patient-Derived Cancer Organoids for Precision Oncology Treatment
por: Pernik, Mark N., et al.
Publicado: (2021)

Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis
por: Berg, Hege F., et al.
Publicado: (2021)

Detection of Experimental Colorectal Peritoneal Metastases by a Novel PDGFRβ-Targeting Nanobody
por: Strating, Esther, et al.
Publicado: (2022)

PDX-derived organoids model in vivo drug response and secrete biomarkers
por: Huang, Ling, et al.
Publicado: (2020)

The Efficacy of Using Patient-Derived Organoids to Predict Treatment Response in Colorectal Cancer
por: Su, Chang, et al.
Publicado: (2023)

Advances of Patient-Derived Organoids in Personalized Radiotherapy
por: Wang, Yuenan, et al.
Publicado: (2022)

The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care
por: Derksen, Jeroen W. G., et al.
Publicado: (2021)

Specialized nutrition improves muscle function and physical activity without affecting chemotherapy efficacy in C26 tumour‐bearing mice
por: Wijler, Liza A., et al.
Publicado: (2021)

Patient-derived spheroids and patient-derived organoids simulate evolutions of lung cancer
por: Surina, et al.
Publicado: (2023)

Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance
por: Gorski, Justin W., et al.
Publicado: (2021)

“Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”
por: Papaccio, Federica, et al.
Publicado: (2023)

Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer
por: Önder, Cansu E., et al.
Publicado: (2023)

Fine-Needle Aspiration-Based Patient-Derived Cancer Organoids
por: Vilgelm, Anna E., et al.
Publicado: (2020)

Establishment of patient-derived organoid models of lower-grade glioma
por: Abdullah, Kalil G, et al.
Publicado: (2021)

Generating Patient-Derived Gliomas within Cerebral Organoids
por: Linkous, Amanda, et al.
Publicado: (2020)

Cholangiocarcinoma Disease Modelling Through Patients Derived Organoids
por: Amato, Francesco, et al.
Publicado: (2020)

Patient-Derived Cancer Organoids as Predictors of Treatment Response
por: Verduin, Maikel, et al.
Publicado: (2021)

Ultrastructural analysis of breast cancer patient-derived organoids
por: Signati, Lorena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h5jabg47aajmi6usqbpmfr6u9k